NYSE:WAL
NYSE:WALBanks

Western Alliance (WAL) Valuation Check After Lawsuit-Linked Shareholder Investigation and Legal Scrutiny

Western Alliance Bancorporation (WAL) has landed in the legal spotlight after suing borrower Cantor Group V LLC over alleged collateral fraud, a move that quickly drew a securities investigation from Rosen Law Firm. See our latest analysis for Western Alliance Bancorporation. Even after the legal flare up around Cantor Group V LLC and the ensuing shareholder probe, Western Alliance Bancorporation's share price has held at about $85.36. Recent multi week share price gains contrast with a...
NasdaqGS:INTU
NasdaqGS:INTUSoftware

Intuit (INTU) Valuation Check After Earnings Beat, Cautious Guidance and Investor Day Growth Update

Intuit (INTU) has been in the spotlight after its latest earnings beat was followed by cautious guidance, a combination that initially pressured the stock but set the stage for a more nuanced investor debate. See our latest analysis for Intuit. Despite the post earnings wobble, Intuit’s 7 day share price return of 6.24% and year to date share price gain of 8.16% suggest momentum is rebuilding. A 3 year total shareholder return of 71.85% underlines that the longer term story remains firmly...
NYSE:CWAN
NYSE:CWANSoftware

Clearwater Analytics (CWAN) Valuation After Enfusion and Beacon Acquisitions Expand Its Growth Platform

Clearwater Analytics Holdings (CWAN) just made a strategic leap by acquiring Enfusion and Beacon, pulling asset managers and hedge funds into its orbit alongside insurers, and the market is starting to reprice that broader opportunity. See our latest analysis for Clearwater Analytics Holdings. The acquisitions come after a sharp 30 day share price return of 34.2 percent, even though the year to date share price return remains down 20.2 percent, and the three year total shareholder return of...
NYSE:DBD
NYSE:DBDTech

Diebold Nixdorf (DBD): Valuation Check After DN Series 300/350 Cash Dispenser Launch

Diebold Nixdorf (DBD) just rolled out its DN Series 300 and 350 cash dispensers, built around the new DM7V module, and this upgrade matters because it directly targets banks cash logistics costs and uptime. See our latest analysis for Diebold Nixdorf. The DN Series rollout lands after a steady rebound in sentiment, with the share price at $65.33 and a strong year to date share price return of 53.72 percent, signaling building momentum despite a more moderate 1 year total shareholder return of...
NYSE:ZETA
NYSE:ZETASoftware

Did Zeta’s Small Equity Raise and Higher 2025–26 Outlook Just Shift ZETA’s Investment Narrative?

Zeta Global Holdings Corp. recently completed a follow-on equity offering of US$0.999997 million, issuing 58,943 Class A common shares at about US$16.97 per share. Just before this capital raise, the company lifted its revenue guidance for late 2025 and 2026, highlighting management’s confidence in integrating Marigold’s enterprise software business into Zeta’s growth plans. We’ll now examine how the upgraded multi-year revenue outlook, including Marigold’s contribution, may influence Zeta...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

Why Intellia Therapeutics (NTLA) Is Up 6.9% After Disclosing Serious Liver Safety Events In Lead CRISPR Trials

Recently, Intellia Therapeutics disclosed serious liver-related safety events, including a case meeting Hy’s law criteria, in its lead in vivo CRISPR programs for hereditary angioedema and transthyretin amyloidosis, raising significant regulatory and clinical concerns. The heightened safety scrutiny is especially important because these programs target diseases that already have multiple approved treatments, potentially weakening Intellia’s competitive position and long-term pipeline...
NYSE:PD
NYSE:PDSoftware

PagerDuty (PD) valuation update after earnings beat, raised guidance, and new AWS resilience competency win

PagerDuty (PD) just put together a stronger earnings story, lifting its full year profit and margin outlook while also securing a new AWS resilience competency that reinforces its role in mission critical cloud operations. See our latest analysis for PagerDuty. Even with the earnings beat and AWS resilience win, sentiment is still catching up. The 90 day share price return of minus 28.48 percent and 1 year total shareholder return of minus 42.27 percent show momentum has been weak despite...
NasdaqGS:GFS
NasdaqGS:GFSSemiconductor

Why GlobalFoundries (GFS) Is Up 8.7% After New U.S. Security Role And Green Targets

Recent developments underscored GlobalFoundries’ role as a core U.S. semiconductor manufacturer, with Department of Defense-trusted supplier status, substantial federal backing, and long-term government and industrial chip contracts embedded in critical aerospace, communications, and military programs. At the same time, GlobalFoundries is expanding a centralized abatement system in Singapore as part of its plan to cut greenhouse gas emissions by 42% from 2021 levels by 2030 and reach net...
NasdaqGM:VITL
NasdaqGM:VITLFood

Needham’s Bullish View on Ethical Scale Might Change The Case For Investing In Vital Farms (VITL)

Earlier this week, Needham initiated coverage on Vital Farms with a Buy rating, citing the company’s capacity expansion, strong consumer demand, and leading position in ethical, pasture-raised eggs and butter. Analysts are increasingly highlighting Vital Farms’ combination of ethical sourcing and operational scale as a potential differentiator within the premium food products space. We’ll now examine how Needham’s upbeat initiation, centered on capacity expansion and ethical leadership,...
NYSE:LNC
NYSE:LNCInsurance

Has the 34% 2025 Rally Left Lincoln National Stock Still Attractively Priced?

Wondering if Lincoln National at around $42.74 is a bargain or a value trap? You are not alone, and we are going to unpack exactly what the market might be missing. The stock has climbed 3.9% over the last week and month, and it is now up 34.2% year to date and 31.3% over the past year, which signals that investor sentiment and expectations have shifted meaningfully. Recently, headlines have focused on Lincoln National's ongoing balance sheet repositioning and strategic initiatives to...
NasdaqGM:APPF
NasdaqGM:APPFSoftware

AppFolio (APPF): Has Recent Share Weakness Created a Quiet Valuation Opportunity?

AppFolio (APPF) has quietly given back some gains over the past month, even as revenue and earnings continue to grow. That mix of share weakness and improving fundamentals sets up an interesting valuation check. See our latest analysis for AppFolio. Over the past year, AppFolio has seen its share price drift lower even as its multi year total shareholder return remains strong. This suggests that recent weakness reflects shifting sentiment more than a broken growth story. If AppFolio’s setup...
NasdaqGS:MYRG
NasdaqGS:MYRGConstruction

Reviewing MYR Group (MYRG)’s Valuation as Electrification and AI Infrastructure Tailwinds Strengthen

MYR Group (MYRG) is back on investors radar after management doubled down on its optimistic outlook for electrification and AI infrastructure, highlighting rising demand and the potential for earnings growth over the next two years. See our latest analysis for MYR Group. Behind that upbeat commentary, MYR Group’s momentum has been strong, with the share price up 54.54% year to date and a standout 149.55% three year total shareholder return, signalling investors are leaning into the long term...
NYSE:TEX
NYSE:TEXMachinery

Terex (TEX): Assessing Valuation After Analyst Upgrades and MAGNA’s European Launch

Terex (TEX) caught investors attention after the stock climbed about 7% following upbeat analyst sentiment and the European debut of its MAGNA brand, a move that underscores managements push into new markets. See our latest analysis for Terex. That upbeat reaction fits a broader pattern, with an 8.3% 1 month share price return and an 11.9% year to date share price gain suggesting momentum is rebuilding even though the 1 year total shareholder return is still slightly negative. If MAGNA’s...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

AXPAXLI NDA Acceleration Might Change The Case For Investing In Ocular Therapeutix (OCUL)

In late 2025, Ocular Therapeutix announced it plans to submit a new drug application for its wet age-related macular degeneration therapy AXPAXLI based on year 1 data from the SOL-1 Phase 3 trial, following updated interactions with the FDA that may allow reliance on a single pivotal study. This shift to an earlier filing, alongside progressing Phase 3 programs in non-proliferative diabetic retinopathy and other ELUTYX-based assets, could materially reshape Ocular’s development timelines...
NYSE:TOL
NYSE:TOLConsumer Durables

Toll Brothers (TOL) Valuation Check After JP Morgan Upgrade and Rising Earnings Expectations

Toll Brothers (TOL) has climbed ahead of the broader market as investors lean into rising expectations for its December 8 earnings, supported by a fresh upgrade from JP Morgan and steady growth in its luxury community pipeline. See our latest analysis for Toll Brothers. The latest pullback in the share price to $138.94 comes after a solid run, with an 11.54% year to date share price return and a powerful 193.58% three year total shareholder return suggesting longer term momentum is still very...
NasdaqCM:BLFS
NasdaqCM:BLFSLife Sciences

BioLife Solutions (BLFS) Valuation After Strong Q3 Beat, Guidance Raise, and New Biopreservation Center Opening

BioLife Solutions (BLFS) has given investors plenty to chew on after Q3, with an earnings beat, stronger revenue guidance for its cell processing platform, and a new biopreservation center opening in Bothell. See our latest analysis for BioLife Solutions. Even with the upbeat Q3 and the new biopreservation center signaling a long runway for its CGT tools, BioLife’s recent share price return has been slightly negative and its 1 year total shareholder return is modestly underwater, suggesting...
NYSE:GLOB
NYSE:GLOBIT

Why Globant (GLOB) Is Up 11.9% After Deepening Its FIFA AI and Salesforce Ties

In late 2025, FIFA announced an expanded agreement with Globant to enhance its digital platforms and build a new mobile app to support multiple tournaments, while naming Globant a Tournament Supporter for the FIFA World Cup 2026 and FIFA Women's World Cup 2027. Coming alongside Globant’s Converge 2025 AI event and top-tier Salesforce recognition, this deeper FIFA collaboration highlights how the company is weaving together sports, cloud, and enterprise AI capabilities across its client...
NYSE:SBR
NYSE:SBROil and Gas

Does Sabine Royalty Trust’s (SBR) Softer Payout Reveal Volume Risk at the Core of Its Story?

In early December 2025, Argent Trust Company, as Trustee of Sabine Royalty Trust, reported preliminary monthly production of 28,904 barrels of oil and 796,698 Mcf of gas, alongside a cash distribution of US$0.196670 per unit payable on December 29 to holders of record on December 15. This lower monthly distribution, driven by reduced oil and gas production despite firmer commodity prices and lower Ad Valorem taxes, highlights how sensitive the trust’s payout is to underlying volume swings...
NYSE:VSCO
NYSE:VSCOSpecialty Retail

Victoria's Secret (VSCO) Is Up 18.7% After Raising 2025 Sales Outlook And Narrowing Losses

Victoria's Secret & Co. has reported its third-quarter 2025 results, with sales rising to US$1,472 million and net loss easing to US$37 million, while also issuing fourth-quarter guidance and lifting its full-year 2025 sales outlook to a range of US$6.45 billion to US$6.48 billion. The combination of higher sales, narrower losses, and an upgraded full-year forecast signals management’s growing confidence in the company’s ongoing brand and operational reset. With full-year sales guidance...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Is There Still Upside in Gilead After Its Strong Multi Year Share Price Rally?

If you are wondering whether Gilead Sciences is still attractively priced today or whether most of the upside is already reflected in the share price, this article will walk you through what the numbers indicate about its current value. After climbing 31.9% year to date and 35.5% over the last year, with the share price now around $121.22, Gilead’s recent pullback of 3.7% over the past week and modest 2.0% gain over the last month suggest that investors are reassessing both its growth story...
NasdaqGS:CLBK
NasdaqGS:CLBKBanks

Columbia Financial (CLBK): Reassessing Valuation After Fed Rate Cut Tailwind and Strong Q3 Revenue Growth

Columbia Financial (CLBK) climbed about 4% after the Federal Reserve's recent rate cut lifted sentiment across community banks, a move that comes in addition to the company’s strong third quarter revenue growth. See our latest analysis for Columbia Financial. The latest move takes Columbia Financial’s 30 day share price return to just over 10%, and while the 1 year total shareholder return remains slightly negative, the recent momentum suggests investors are warming to its improving earnings...
NYSE:ESAB
NYSE:ESABMachinery

ESAB (NYSE:ESAB) Valuation Check After Strong Q3 Beat, Raised Guidance and New AI-Focused Board Appointment

ESAB (ESAB) just delivered stronger than expected third quarter results, raised its full year outlook, and added AI specialist Dr. Sébastien Martin to its board. This combination sharpens the stock’s long term execution story. See our latest analysis for ESAB. Even with today’s solid update and dividend declaration, the stock has lost ground recently, with a year to date share price return of negative 6.5 percent and a one year total shareholder return of negative 13.6 percent. However, the...
NYSE:CI
NYSE:CIHealthcare

How Cigna’s PBM Shift to Transparent Fees and New Probe Will Impact Cigna Group (CI) Investors

Cigna Group recently announced a major overhaul of its Evernorth pharmacy benefit management business, shifting from a traditional rebate-based model to a more transparent fee-based structure that it expects will temporarily pressure profits before margins eventually stabilize. This change, alongside a new shareholder investigation into potential disclosure issues, puts a spotlight on how Cigna balances PBM transparency, regulation, and long-term earnings power. We’ll now examine how Cigna’s...
NYSE:BJ
NYSE:BJConsumer Retailing

BJ’s Wholesale Club (BJ): Assessing Valuation as New Springfield, Sumter and Casselberry Openings Signal Renewed Expansion

BJ's Wholesale Club Holdings (BJ) is back in expansion mode, rolling out three new clubs and gas stations this December in Massachusetts, South Carolina, and Florida, a fresh signal of confidence in its core markets. See our latest analysis for BJ's Wholesale Club Holdings. Despite this measured rollout, the stock has been treading water lately, with a slightly negative 3 month share price return but still a positive year to date share price return. At the same time, a strong 5 year total...